Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care
Klaus Pantel, Chairman of the Institute of Tumor Biology at University Medical Center Hamburg-Eppendorf, reviews how liquid biopsy analyses can provide information for the early detection of cancer and identify cancer patients at risk of relapse. The approach may also serve to monitor tumor evolution, therapeutic targets, or mechanisms of resistance on metastatic cells.
Liquid biopsies show particular promise for metastatic cancers. Repeated needle biopsies of metastatic lesions are invasive and some locations are difficult to access. In contrast, monitoring of blood samples is only minimally invasive and can identify tumor evolution and tumor subtype switches, which may then lead to the selection of appropriate therapies based on the molecular composition of recurrent metastases.
Prof. Klaus Pantel also discusses the importance of technical standardization and clinical validation of liquid biopsy assays.
Dr. Alexander Sartori from Agena Bioscience follows up with an overview of Agena’s MassARRAY® System and available variant panels for circulating cell-free DNA in various cancers.
Recorded September 30, 2021
Видео Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care канала Agena Bioscience
Liquid biopsies show particular promise for metastatic cancers. Repeated needle biopsies of metastatic lesions are invasive and some locations are difficult to access. In contrast, monitoring of blood samples is only minimally invasive and can identify tumor evolution and tumor subtype switches, which may then lead to the selection of appropriate therapies based on the molecular composition of recurrent metastases.
Prof. Klaus Pantel also discusses the importance of technical standardization and clinical validation of liquid biopsy assays.
Dr. Alexander Sartori from Agena Bioscience follows up with an overview of Agena’s MassARRAY® System and available variant panels for circulating cell-free DNA in various cancers.
Recorded September 30, 2021
Видео Webinar: The Promise of Liquid Biopsy for Individualizing Cancer Care канала Agena Bioscience
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Webinar: Validating a Diagnostic Mass Spec Platform for a Molecular Pathology Service Lab
Detection & Discrimination of SARS-CoV-2 Variants of Concern - An Alternative Approach to NGS
Webinar: Novel Approach for Multiplex Ultrasensitive Detection
Webinar: Targeted Detection of MET and NTRK Oncogenic Variants in Routine Molecular Analysis
Webinar: Rapid Deployment of Custom Multiplexed Assays for Clinical & Translational Research Labs
Webinar: Hereditary Cancer Risk Assessment – Benefit vs. Cost in Precision Medicine
Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories Perspectives
Webinar: Recent Developments in PGx – Predictive Biomarker Identification and Relevance
Webinar: Sample Identification with the MassARRAY® System
Webinar: Routine Pharmacogenetics Analysis Using Robust Genotyping
AMP 2019 PGx Workshop: The Prevalence and Impact of CYP2D6 Hybrid Alleles
Advocating for DPYD Testing to Advance Patient Safety Based on Insights from Clinical Evidence
Webinar: Detection of therapeutically targetable mutations in NSCLC
Rethinking Solid Tumor Profiling: How Complementary Technologies Allow Better Treatment Decisions
MassARRAY® System by Agena Bioscience – 2020
Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting
Webinar: Evaluating Drug-Drug Interactions: Implications of Phenoconversions
Webinar: Applications and Challenges of Using ctDNA as Non-Invasive Tumor Markers
Webinar: Going beyond EGFR: Evaluating technologies for molecular genetic testing in NSCLC
Hybrid Alleles: Why It's Important to Detect Them & How Agena Does it Better